Financhill
Buy
59

BCHMY Quote, Financials, Valuation and Earnings

Last price:
$7.24
Seasonality move :
-1.23%
Day range:
$7.24 - $7.24
52-week range:
$5.50 - $8.77
Dividend yield:
0.71%
P/E ratio:
35.13x
P/S ratio:
6.95x
P/B ratio:
3.61x
Volume:
--
Avg. volume:
9.9K
1-year change:
15.66%
Market cap:
$5.4B
Revenue:
$687.3M
EPS (TTM):
$0.21

Analysts' Opinion

  • Consensus Rating
    No consensus rating exists at this time due to lack of analyst coverage.
  • Price Target Downside
    No price target exists because of limited analyst coverage.
  • Price Target Upside
    Similarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.

Fair Value

  • According to the consensus of 0 analysts, Bachem Holding AG has -- downside to fair value with a price target of -- per share.

BCHMY vs. S&P 500

  • Over the past 5 trading days, Bachem Holding AG has overperformed the S&P 500 by 5.63% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Bachem Holding AG does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Bachem Holding AG has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Bachem Holding AG reported revenues of --.

Earnings Growth

  • Bachem Holding AG has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Bachem Holding AG reported earnings per share of --.
Enterprise value:
6.1B
EV / Invested capital:
--
Price / LTM sales:
6.95x
EV / EBIT:
34.74x
EV / Revenue:
7.69x
PEG ratio (5yr expected):
0.75x
EV / Free cash flow:
-39.29x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
27.54x
Gross Profit (TTM):
$244M
Return On Assets:
7.29%
Net Income Margin (TTM):
19.78%
Return On Equity:
9.99%
Return On Invested Capital:
9.99%
Operating Margin:
--
Trailing 12 Months Fiscal Quarters
Period Ending 2023-12-28 2024-12-28 2024-12-28
Income Statement
Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
Operating Income -- -- -- -- --
EBITDA -- -- -- -- --
Diluted EPS -- -- -- -- --
Period Ending 2021-06-30 2022-06-30 2023-06-30 2024-06-30 2025-06-30
Balance Sheet
Current Assets $400.1M $757.9M $867.6M $831.6M $889.9M
Total Assets $834.9M $1.3B $1.7B $1.9B $2.4B
Current Liabilities $261.6M $106.9M $222.9M $243.5M $365.1M
Total Liabilities $305.3M $156.3M $278.9M $461.7M $689.8M
Total Equity $529.6M $1.2B $1.4B $1.5B $1.7B
Total Debt -- -- -- -- --
Trailing 12 Months Fiscal Quarters
Period Ending 2023-12-28 2024-12-28 2024-12-28
Cash Flow Statement
Cash Flow Operations -- -- -- -- --
Cash From Investing -- -- -- -- --
Cash From Financing -- -- -- -- --
Free Cash Flow -- -- -- -- --
BCHMY
Sector
Market Cap
$5.4B
$28.2M
Price % of 52-Week High
82.55%
51.2%
Dividend Yield
0.71%
0%
Shareholder Yield
1.36%
-1.54%
1-Year Price Total Return
15.66%
-18.1%
Beta (5-Year)
--
0.516
Dividend yield:
0.71%
Annualized payout:
$0.08
Payout ratio:
-23.95%
Growth streak:
0 years

Technicals

8-day SMA
Buy
Level $6.98
200-day SMA
Buy
Level $7.01
Bollinger Bands (100)
Sell
Level 6.81 - 8.21
Chaikin Money Flow
Sell
Level -17.8K
20-day SMA
Buy
Level $6.87
Relative Strength Index (RSI14)
Buy
Level 60.58
ADX Line
Buy
Level 25.25
Williams %R
Neutral
Level -24.6154
50-day SMA
Buy
Level $6.89
MACD (12, 26)
Buy
Level 0.08
25-day Aroon Oscillator
Buy
Level 88
On Balance Volume
Sell
Level -79.3K

Financial Scores

Buy
Altman Z-Score (Annual)
Level (6.4214)
Buy
CA Score (Annual)
Level (1.1553)
Buy
Beneish M-Score (Annual)
Level (-2.3783)
Buy
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-2.2027)
Buy
Piotroski F Score (Annual)
Level (5)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Bachem Holding AG engages in the provision of peptides and oligonucleotides. It operates through the Europe/Asia and North America geographical segments. It offers project management, research grade production, catalog peptides, peptide NCES, and commercial NCES. The company was founded in 2003 and is headquartered in Bubendorf, Switzerland.

Stock Forecast FAQ

In the current month, BCHMY has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The BCHMY average analyst price target in the past 3 months is --.

  • Where Will Bachem Holding AG Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Bachem Holding AG share price will drop to -- per share over the next 12 months.

  • What Do Analysts Say About Bachem Holding AG?

    Analysts are divided on their view about Bachem Holding AG share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Bachem Holding AG is a Sell and believe this share price will rise from its current level to --.

  • What Is Bachem Holding AG's Price Target?

    The price target for Bachem Holding AG over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is BCHMY A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Bachem Holding AG is a --. 0 of 0 analysts rate the stock a -- at this time.

  • How Can I Buy Shares Of BCHMY?

    You can purchase shares of Bachem Holding AG via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Bachem Holding AG shares.

  • What Is The Bachem Holding AG Share Price Today?

    Bachem Holding AG was last trading at $7.24 per share. This represents the most recent stock quote for Bachem Holding AG. Yesterday, Bachem Holding AG closed at $7.24 per share.

  • How To Buy Bachem Holding AG Stock Online?

    In order to purchase Bachem Holding AG stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
72
GLTO alert for Dec 27

Galecto, Inc. [GLTO] is up 16.92% over the past day.

Sell
20
SMX alert for Dec 27

SMX (Security Matters) Plc [SMX] is down 15.76% over the past day.

Sell
11
CDNAF alert for Dec 27

Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock